A curious time to become impatient after 18 months of positioning, active accumulation and broker control to reach
partner envisaged entry price ranges to commit on positive last minute tox trial additions.
The hard yards are done, this entity is about to enter new trading patterns and price developments on the heels of silent achievements accumulated during a very average period for the common investor.
Only thing to do in such an environment is to take advantage of the market disinterest and capitalise on
subdued prices and add to one’s position .
In biotech terms, we are at truly exciting times for this company. It takes a slightly contrarian view
to market to realise.
all IMO
A curious time to become impatient after 18 months of...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.5¢ | $182.4K | 1.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 338966 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 244886 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |